Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Educational Costs Expended and Career Incomes in Advanced Healthcare Professions.
Journal: AANA journal
Published: January 30, 2024
Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration.
Journal: Ophthalmology and therapy
Published: March 20, 2023
Preference-based comparison of quality of life associated with vision loss in Black and White ophthalmic populations in the US.
Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
Published: June 22, 2022
Re: Le et al.: Associations between age-related eye diseases and Charles Bonnet Syndrome in participants of the Age-Related Eye Disease Study 2: Report Number 26 (Ophthalmology. 2022;129:233-235).
Journal: Ophthalmology
Published: February 01, 2022
Quality of life associated with no light perception vision.
Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
Published: June 04, 2021
Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis.
Journal: JAMA ophthalmology
Published: February 04, 2021
Vision-related quality-of-life estimates in adolescent youths.
Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
Published: November 14, 2020
Reply to Comment on: Cost-Effectiveness of Limited Vitrectomy for Vision Degrading Myodesopsia.
Journal: American journal of ophthalmology
Published: January 10, 2020
Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration.
Journal: American journal of ophthalmology
Published: August 22, 2019
A Cost-Benefit Analysis of VEGF-Inhibitor Therapy for Neovascular Age-Related Macular Degeneration in the United States.
Journal: American journal of ophthalmology
Published: August 22, 2019
Last Updated: 09/26/2026